Metformin role in Parkinson's disease: a double-sword effect

M Alrouji, HM Al-Kuraishy, AI Al-Gareeb… - Molecular and Cellular …, 2024 - Springer
Parkinson's disease (PD) is a common neurodegenerative disease developed due to the
degeneration of dopaminergic neurons in the substantia nigra. There is no single effective …

Theophylline: Old drug in a new light, application in COVID-19 through computational studies

LM Montaño, B Sommer, JC Gomez-Verjan… - International Journal of …, 2022 - mdpi.com
Theophylline (3-methyxanthine) is a historically prominent drug used to treat respiratory
diseases, alone or in combination with other drugs. The rapid onset of the COVID-19 …

Significant impact of time-of-day variation on metformin pharmacokinetics

D Türk, N Scherer, D Selzer, C Dings, N Hanke… - Diabetologia, 2023 - Springer
Aims/hypothesis The objective was to investigate if metformin pharmacokinetics is
modulated by time-of-day in humans using empirical and mechanistic pharmacokinetic …

Development and evaluation of physiologically based pharmacokinetic drug-disease models for predicting captopril pharmacokinetics in chronic diseases

MF Rasool, S Ali, S Khalid, R Khalid, A Majeed… - Scientific Reports, 2021 - nature.com
The advancement in the processing speeds of computing machines has facilitated the
development of complex physiologically based pharmacokinetic (PBPK) models. These …

Physiologically based metformin pharmacokinetics model of mice and scale-up to humans for the estimation of concentrations in various tissues

DM Zake, J Kurlovics, L Zaharenko, V Komasilovs… - PLoS …, 2021 - journals.plos.org
Metformin is the primary drug for type 2 diabetes treatment and a promising candidate for
other disease treatment. It has significant deviations between individuals in therapy …

Renal Transporter‐Mediated Drug‐Biomarker Interactions of the Endogenous Substrates Creatinine and N1‐Methylnicotinamide: A PBPK Modeling Approach

D Türk, F Müller, MF Fromm, D Selzer… - Clinical …, 2022 - Wiley Online Library
Endogenous biomarkers for transporter‐mediated drug‐drug interaction (DDI) predictions
represent a promising approach to facilitate and improve conventional DDI investigations in …

Physiologically‐based pharmacokinetic modeling of dextromethorphan to investigate interindividual variability within CYP2D6 activity score groups

S Rüdesheim, D Selzer, U Fuhr… - CPT …, 2022 - Wiley Online Library
This study provides a whole‐body physiologically‐based pharmacokinetic (PBPK) model of
dextromethorphan and its metabolites dextrorphan and dextrorphan O‐glucuronide for …

Generic Workflow to Predict Medicine Concentrations in Human Milk Using Physiologically-Based Pharmacokinetic (PBPK) Modelling—A Contribution from the …

N Nauwelaerts, J Macente, N Deferm, RH Bonan… - Pharmaceutics, 2023 - mdpi.com
Women commonly take medication during lactation. Currently, there is little information
about the exposure-related safety of maternal medicines for breastfed infants. The aim was …

Integrated or independent actions of metformin in target tissues underlying its current use and new possible applications in the endocrine and metabolic disorder area

G Tulipano - International journal of molecular sciences, 2021 - mdpi.com
Metformin is considered the first-choice drug for type 2 diabetes treatment. Actually,
pleiotropic effects of metformin have been recognized, and there is evidence that this drug …

Meta-assessment of metformin absorption and disposition pharmacokinetics in nine species

YS Jeong, WJ Jusko - Pharmaceuticals, 2021 - mdpi.com
The objective of this study was to systematically assess literature datasets and quantitatively
analyze metformin PK in plasma and some tissues of nine species. The pharmacokinetic …